Fig. 2From: Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibitionCharacteristics of the six patients suffering from HBV reactivation. HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; PD-1, programmed cell death 1; PD-L1, programmed cell death-ligand 1; NPC, nasopharyngeal carcinoma; HCC, hepatocellular carcinoma; HNSCC, head and neck squamous cancerBack to article page